Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully autom... T2 Biosystems Inc provides rapid in vitro diagnostic tests to hospitals and laboratories. The company's core technology is T2 Magnetic Resonance (T2MR) technology, which can detect a variety of molecular targets directly from whole blood. T2MR technology enables the T2Dx system, which is fully automated from patient sample to result for its panels focused on bacterial and fungal infections that could cause sepsis, and its pipeline panel for Lyme disease. Mehr anzeigen
LEXINGTON, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance...
LEXINGTON, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0415 | 8.4693877551 | 0.49 | 0.7 | 0.47 | 1492616 | 0.55717859 | CS |
| 4 | -0.2618 | -33.0013866129 | 0.7933 | 0.825 | 0.4156 | 1222877 | 0.5406068 | CS |
| 12 | -2.2585 | -80.9498207885 | 2.79 | 2.8394 | 0.4156 | 744886 | 0.96287732 | CS |
| 26 | -4.5985 | -89.6393762183 | 5.13 | 6.8 | 0.4156 | 437139 | 1.64465439 | CS |
| 52 | -3.2585 | -85.9762532982 | 3.79 | 8.3799 | 0.4156 | 391059 | 3.06958313 | CS |
| 156 | -2902.4685 | -99.9816913538 | 2903 | 3050 | 0.4156 | 17380550 | 216.83058866 | CS |
| 260 | -6349.4685 | -99.9916299213 | 6350 | 18950 | 0.4156 | 13297091 | 1650.62268876 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
